14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism.
Peking Union Medical College and Chinese Academy of Medical Sciences
Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2.
Kunming Institute of Botany
Discovery of honokiol thioethers containing 1,3,4-oxadiazole moieties as potential ?-glucosidase and SARS-CoV-2 entry inhibitors.
Zhengzhou University
Identification, optimization, and biological evaluation of 3-O-?-chacotriosyl ursolic acid derivatives as novel SARS-CoV-2 entry inhibitors by targeting the prefusion state of spike protein.
South China Agricultural University
Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins.
Keio University
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.
University of California San Diego
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.
University of Groningen
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization.
University of Salerno
Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor.
Second Military Medical University
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
University of California San Francisco (Ucsf)